Cargando…
Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits
Breast cancer and prostate cancer are the most common cancers diagnosed in women and men, respectively, in the UK, and radiotherapy is used extensively in the treatment of both. In vitro data suggest that tumours in the breast and prostate have unique properties that make a hypofractionated radiothe...
Autores principales: | Ray, K.J., Sibson, N.R., Kiltie, A.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465964/ https://www.ncbi.nlm.nih.gov/pubmed/25752244 http://dx.doi.org/10.1016/j.clon.2015.02.008 |
Ejemplares similares
-
Corrigendum to “Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits” [Clin Oncol 27 (7) (2015) 420–426]
por: Ray, K.J., et al.
Publicado: (2016) -
Focal Therapy for Prostate Cancer: Rationale and Treatment Opportunities
por: Kasivisvanathan, V., et al.
Publicado: (2013) -
Twenty years of Medicare and Medicaid: Covered populations, use of benefits, and program expenditures
por: Gornick, Marian, et al.
Publicado: (1985) -
Co-enrolment of Participants into Multiple Cancer Trials: Benefits and Challenges
por: Cafferty, F.H., et al.
Publicado: (2017) -
Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)